Topical advances in wound care

Gynecologic Oncology

Volumn 111, Issue 2 SUPPL., 2008, Pages

  Stojadinovic, Alexander ^a,c   Carlson, Jay W ^d   Schultz, Gregory S ^e   Davis, Thomas A ^a,b,c   Elster, Eric A ^a,b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c Combat Wound Initiative ^*  (United States)

^d Gynecologic Oncology of West Michigan   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chronic wound; Wound bed preparation; Wound healing

Indexed keywords

ACETIC ACID; BECAPLERMIN; BEVACIZUMAB; CADEXOMER IODINE; CHLORHEXIDINE; CORTICOSTEROID; CRYSTAL VIOLET; GENTAMICIN; IODINE; IODOFLEX; MAFENIDE; METRONIDAZOLE; PSEUDOMONIC ACID; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CONTAMINATION; DEBRIDEMENT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIA; PRIORITY JOURNAL; STRESS; TISSUE NECROSIS; TREATMENT INDICATION; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

BANDAGES; CHRONIC DISEASE; HUMANS; WOUND HEALING; WOUND INFECTION; WOUNDS AND INJURIES;

EID: 54549083113     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.042     Document Type: Article

References (100)

1. Witte M.B., and Barbul A. General principles of wound healing. Surg. Clin. North Am. 77 (1997) 509-528
2. Broughton II G., Janis J.E., and Attinger C.E. The basic science of wound healing. Plast. Reconstr. Surg. 117 7 Suppl (2006) 12S-34S
3. Grotendorst G.R., Soma Y., Takehara K., and Charette M. EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J. Cell. Physiol. 139 (1989) 617-623
4. Henry G., and Garner W.L. Inflammatory mediators in wound healing. Surg. Clin. North Am. 83 (2003) 483-507
5. Goldman R. Growth factors and chronic wound healing: past, present and future. Adv. Skin. Wound Care 17 (2004) 24-35
6. Grinell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol. 13 (2003) 264-269
7. Lawrence W., and Diegelmann R. Growth factors in wound healing. Clin. Dermatol. 12 (1994) 157-169
8. Schultz G.S., and Mast B.A. Molecular analysis of the environment of healing and chronic wounds: cytokines, proteases and growth factors. Wounds 10 (1998) 1F-9F
9. Mast B.A., and Schultz G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 4 (1996) 411-420
10. Mustoe T.A. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. 187 5A (2004) 65S-70S
11. Bozzetti F., Gavazzi C., Miceli R., Rossi N., Mariani L., Cozzaglio L., et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J. Parenter. Enteral. Nutr. 24 (2000) 7-14
12. Wu G.H., Liu Z.H., Wu Z.H., and Wu Z.G. Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J. Gastroenterol. 12 (2006) 2441-2444
13. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N. Engl. J. Med. 325 (1991) 525-532
14. Anstead G.M. Steroids, retinoids, and wound healing. Adv. Wound Care 11 (1998) 277-285
15. Dronge A.S., Perkal M.F., Kancir S., Concato J., Aslan M., and Rosenthal R.A. Long-term glycemic control and postoperative infectious complications. Arch. Surg. 141 (2006) 375-380
16. Scher K.S. Studies on the duration of antibiotic administration for surgical prophylaxis. Am. Surg. 63 (1997) 59-62
17. Bratzler D.W., Houck P.M., and Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 189 (2005) 395-404
18. Haley R.W., Culver D.H., Morgan W.M., White J.W., Emori T.G., and Hooton T.M. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am. J. Epidemiol. 121 (1985) 206-215
19. Greif R., Akça O., Horn E.P., Kurz A., Sessler D.I., and Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N. Engl. J. Med. 342 (2000) 161-167
20. Brandstrup B., Tønnesen H., Beier-Holgersen R., Hjortsø E., Ørding H., Lindorff-Larsen K., et al., Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann. Surg. 238 (2003) 641-648
21. Schultz G.S., Sibbald R.G., Falanga V., Ayello E.A., Dowsett C., Harding K., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 11 Suppl 1 (2003) S1-S28
22. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 8 (2000) 347-352
23. Granick M., Boykin J., Gamelli R., Schultz G., and Tenenhaus M. Toward a common language: surgical wound bed preparation and debridement. Wound Repair Regen. 14 S1 (2006) 1-10
24. Thompson J.T., and Marks M.W. Negative pressure wound therapy. Clin. Plast. Surg. 34 (2007) 673-684
25. Hunter J.E., Teot L., Horch R., and Banwell P.E. Evidence-based medicine: vacuum-assisted closure in wound care management. Int. Wound J. 4 (2007) 256-269
26. Granick M.S., Posnett J., Jacoby M., Noruthun S., Ganchi P.A., and Datiashvili R.O. Efficacy and cost-effectiveness of a high-powered parallel waterjet for wound debridement. Wound Repair Regen. 14 (2006) 394-397
27. Granick M.S., Tenenhaus M., Knox K.R., and Ulm J.P. Comparison of wound irrigation and tangential hydrodissection in bacterial clearance of contaminated wounds: results of a randomized, controlled clinical study. Ostomy. Wound Manage 53 (2007) 64-66-68-70
28. Young L.S., Sabel A.L., and Price C.S. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect. Control Hosp. Epidemiol. 28 (2007) 1247-1254
29. Granick M.S., Posnett J., Jacoby M., Noruthun S., Ganchi P.A., and Datiashvili R.O. Efficacy and cost-effectiveness of a high-powered parallel waterjet for wound debridement. Wound Repair Regen. 14 (2006) 394-397
30. König M., Vanscheidt W., Augustin M., and Kapp H. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J. Wound Care 14 (2005) 320-323
31. Steed D.L. Debridement. Am. J. Surg. 187 (2004) 71S-74S
32. Gupta A. A review of the use of maggots in wound therapy. Ann. Plast. Surg. 60 (2008) 224-227
33. Sherman R.A., Sherman J., Gilead L., Lipo M., and Mumcuoglu K.Y. Maggot débridement therapy in outpatients. Arch. Phys. Med. Rehabil. 82 (2001) 1226-1229
34. Steenvoorde P., Jacobi C.E., Van Doorn L., and Oskam J. Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds. Ann. R. Coll. Surg. Engl. 89 (2007) 596-602
35. Helgeson M.D., Potter B.K., Evans K.N., and Shawen S.B. Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds. J. Orthop. Trauma. 21 (2007) 394-399
36. Robson M.C., and Heggers J. Delayed wound closures based on bacterial counts. J. Surg. Oncol. 2 (1970) 379-383
37. Robson M.C., Edstrom L.E., Krizek T.J., and Groskin M.G. The efficacy of systemic antibiotics in the treatment of granulating wounds. J. Surg. Res. 16 (1974) 299-306
38. Robson M.C. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg. Clin. North Am. 77 (1997) 637-651
39. J. Hawksworth, M.R. Kasper, F. Gage, T. Brown, D.K. Tadaki, P.W. Perdue, et al. Quantitative bacteriology and wound failure in high energy penetrating war injuries. Academic Surgical Congress, 3rd Annual Meeting, Huntington Beach, CA, February 12-15, 2008.
40. Sibbald R.G., Williamson D., Orsted H.L., Campbell K., Keast D., Krasner D., et al. Preparing the wound bed-debridement, bacterial balance, and moisture balance. Ostomy. Wound Manage 46 (2000) 24-28-30-35 [quiz 36-7]
41. Moberg S., Hoffman L., Grennert M., and Holst A. A randomized trial of cadexomer iodine in decubitus ulcers. J. Am. Geriatr. Soc. 31 (1983) 462-465
42. Ohtani T., Mizuashi M., Ito Y., and Aiba S. Cadexomer as well as cadexomer iodine induces the production of preinflammatory cytokines and vascular endothelial growth factor by human macrophages. Exp. Dermatology. 16 (2007) 318-323
43. Livingston D.H., Cryer H.G., Miller F.B., Malangoni M.A., Polk Jr. H.C., and Weiner L.J. A randomized prospective study of topical antimicrobial agents on skin grafts after thermal injury. Plast. Reconstr. Surg. 86 (1990) 1059-1064
44. Tredget E.E., Shankowsky H.A., Groeneveld A., and Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J. Burn Care Rehabil. 19 (1998) 531-537
45. Münter K.C., Beele H., Russell L., Crespi A., Gröchenig E., Basse P., et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J. Wound Care 15 (2006) 199-206
46. Argirova M., Hadjiski O., and Victorova A. Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study. Ann. Plast. Surg. 59 (2007) 415-422
47. Huang Y., Li X., Liao Z., Zhang G., Liu Q., Tang J., et al. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 33 (2007) 161-166
48. Demling R.H., and Leslie DeSanti M.D. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns 28 (2002) 264-266
49. Sibbald R.G., Williamson D., Orsted H.L., Campbell K., Keast D., Krasner D., et al. Preparing the wound bed-debridement, bacterial balance, and moisture balance. Ostomy. Wound Manage 46 (2000) 24-28-30-35 [quiz 36-7]
50. Sibbald R.G., Schultz G.S., Coutts P., Orsted H., and Keast D. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy. Wound Manage 49 (2003) 24-51
51. Sibbald R.G. Topical antimicrobials. Ostomy. Wound Manage 49 5A-suppl (2003) 3-33
52. Tredget E.E., Shankowsky H.A., Rennie R., Burrell R.E., and Logsetty S. Pseudomonas infections in the thermally injured patient. Burns 30 (2004) 3-26
53. Robson M.C., Edstrom L.E., Krizek T.J., and Groskin M.G. The efficacy of systemic antibiotics in the treatment of granulating wounds. J. Surg. Res. 16 (1974) 299-306
54. Ovington L.G. Dressings and adjunctive therapies: aBCPR guidelines revisited. Ostomy. Wound Manage 45 (1999) 94S-106S
55. Gottrup F., Jørgensen B., Karlsmark T., Sibbald R.G., Rimdeika R., Harding K., et al. Less pain with Biatain-Ibu: initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers. Int. Wound J. 4 Suppl 1 (2007) 24-34
56. Jørgensen B., Friis G.J., and Gottrup F. Pain and quality of life for patients with venous leg ulcers: proof of concept of the efficacy of Biatain-Ibu, a new pain reducing wound dressing. Wound Repair Regen. 14 (2006) 233-239
57. Sibbald R.G., Coutts P., Fierheller M., and Woo K. A pilot (real-life) randomised clinical evaluation of a pain-relieving foam dressing: (ibuprofen-foam versus local best practice). Int. Wound J. 4 Suppl 1 (2007) 16-23
58. Yannas I.V., Burke J.F., Gordon P.L., Huang C., and Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J. Biomed. Mater. Res. 14 (1980) 107-132
59. Achauer B.M., VanderKam V.M., Celikoz B., and Jacobson D.G. Augmentation of facial soft-tissue defects with Alloderm dermal graft. Ann. Plast. Surg. 41 (1998) 503-507
60. Aycock J., Fichera A., Colwell J.C., and Song D.H. Parastomal hernia repair with acellular dermal matrix. J. Wound Ostomy. Continence Nurs. 34 (2007) 521-523
61. Breuing K.H., and Warren S.M. Immediate bilateral breast reconstruction with implants and inferolateral AlloDerm slings. Ann. Plast. Surg. 55 (2005) 232-239
62. Breuing K.H., and Colwell A.S. Inferolateral AlloDerm Hammock for implant coverage in breast reconstruction. Ann. Plast. Surg. 59 (2007) 250-255
63. Buinewicz B., and Rosen B. Acellular cadaveric dermis (AlloDermÒ): a new alternative for abdominal hernia repair. Ann. Plast. Surg. 52 (2004) 188-194
64. Butler C.E., Langstein H.N., and Kronowitz S.J. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast. Reconstr. Surg. 116 (2005) 1263-1275 [discussion 1276-7]
65. Butler C.E., and Prieto V.G. Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction. Plast. Reconstr. Surg. 114 (2004) 464-473
66. Butler C.E., Langstein H.N., and Kronowitz S.J. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast. Reconstr. Surg. 116 (2005) 1263-1275 [discussion 1276-7]
67. Diaz Jr. J.J., Guy J., Berkes M.B., Guillamondegui O., and Miller R.S. Acellular dermal allograft for ventral hernia repair in the compromised surgical field. Am. Surg. 72 (2006) 1181-1187 [discussion 1187-8]
68. Espinosa-de-los-Monteros A., de la Torre J.I., Marrero I., Andrades P., Davis M.R., and Vasconez L.O. Utilization of human cadaveric acellular dermis for abdominal hernia reconstruction. Ann. Plast. Surg. 58 (2007) 264-267
69. Fisher E., and Frodel J.L. Facial suspension with acellular human dermal allograft. Arch. Facial Plast. Surg. 1 (1999) 195-199
70. Glasberg S.B., and D'Amico R.A. Use of regenerative human acellular tissue (AlloDerm) to reconstruct the abdominal wall following pedicle TRAM flap breast reconstruction surgery. Plast. Reconstr. Surg. 118 (2006) 8-15
71. Gore D.C. Utility of acellular allograft dermis in the care of elderly burn patients. J. Surg. Res. 125 (2005) 37-41
72. Govindaraj S., Cohen M., Genden E.M., Costantino P.D., and Urken M.L. The use of acellular dermis in the prevention of Frey's syndrome. Laryngoscope 111 11 Pt 1 (2001) 1993-1998
73. Gryskiewicz J.M., Rohrich R.J., and Reagan B.J. The use of AlloDerm for the correction of nasal contour deformities. Plast. Reconstr. Surg. 107 (2001) 561-570 [discussion 571]
74. Guy J.S., Miller R., Morris Jr. J.A., Diaz J., and May A. Early one-stage closure in patients with abdominal compartment syndrome: fascial replacement with human acellular dermis and bipedicle flaps. Am. Surg. 69 (2003) 1025-1028
75. Kim H., Bruen K., and Vargo D. Acellular dermal matrix in the management of high-risk abdominal wall defects. Am. J. Surg. 192 (2006) 705-709
76. Kish K.J., Buinewicz B.R., and Morris J.B. Acellular dermal matrix (AlloDerm): new material in the repair of stoma site hernias. Am. Surg. 71 (2005) 1047-1050
77. Kolker A.R., Brown D.J., Redstone J.S., Scarpinato V.M., and Wallack M.K. Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation. Ann. Plast. Surg. 55 (2005) 36-42
78. Kridel R.W., Foda H., and Lunde K.C. Septal perforation repair with acellular human dermal allograft. Arch. Otolaryngol. Head Neck Surg. 124 (1998) 73-78
79. Patton Jr. J.H., Berry S., and Kralovich K.A. Use of human acellular dermal matrix in complex and contaminated abdominal wall reconstructions. Am. J. Surg. 193 (2007) 360-363
80. Rosales M.A., Bruntz M., and Armstrong D.G. Gamma-irradiated human skin allograft: a potential treatment modality for lower extremity ulcers. Int. Wound J. 1 (2004) 201-206
81. Rubin P.A., Fay A.M., Remulla H.D., and Maus M. Ophthalmic plastic applications of acellular dermal allografts. Ophthalmology 106 (1999) 2091-2097
82. Salzberg C.A. Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft (AlloDerm). Ann. Plast. Surg. 57 (2006) 1-5
83. Scott B.G., Welsh F.J., Pham H.Q., Carrick M.M., Liscum K.R., Granchi T.S., et al. Early aggressive closure of the open abdomen. J. Trauma. 60 (2006) 17-22
84. Sheridan R., Choucair R., Donelan M., Lydon M., Petras L., and Tompkins R. Acellular allodermis in burns surgery: 1-year results of a pilot trial. J. Burn Care Rehabil. 19 (1998) 528-530
85. Sinha U.K., Saadat D., Doherty C.M., and Rice D.H. Use of AlloDerm implant to prevent Frey syndrome after parotidectomy. Arch. Facial Plast. Surg. 5 (2003) 109-112
86. Terino E.O. Alloderm acellular dermal graft: applications in aesthetic soft-tissue augmentation. Clin. Plast. Surg. 28 (2001) 83-99
87. Wainwright D., Madden M., Luterman A., Hunt J., Monafo W., Heimbach D., et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J. Burn Care Rehabil. 17 (1996) 124-136
88. Eppley B.L. Revascularization of acellular human dermis (alloderm) in subcutaneous implantation. Aesth. Surg. J. 20 (2000) 291-295
89. Girard S., Sideman M., and Spain D.A. A novel approach to the problem of intestinal fistulization arising in patients managed with open peritoneal cavities. Am. J. Surg. 184 (2002) 166-167
90. Veves A., Falanga V., Armstrong D.G., Sabolinski M.L., and Apligraf Diabetic Foot Study. Graftskin, a human skin equivalent is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24 (2001) 290-295
91. Falanga V., and Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 7 (1999) 201-207
92. Waymack P., Duff R.G., and Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns 26 (2000) 609-619
93. Smiell J.M., Wieman T.J., Steed D.L., Perry B.H., Sampson A.R., and Schwab B.H. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 7 (1999) 335-346
94. Rees R.S., Robson M.C., Smiell J.M., and Perry B.H. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen. 7 (1999) 141-147
95. Wieman T.J. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Am. J. Surg. 176 2A Suppl (1998) 74S-79S
96. Wieman T.J., Smiell J.M., and Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 21 (1998) 822-827
97. Steed D.L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J. Vasc. Surg. 21 (1995) 71-78 [discussion 79-81]
98. Shackelford D.P., Fackler E., Hoffman M.K., and Atkinson S. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Am. J. Obstet. Gynecol. 186 (2002) 701-704
99. Kallianinen L.K., Hirshberg J., Marchant B., and Rees R.S. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers. Plast. Reconstr. Surg. 106 (2000) 1243-1248
100. Ma B., Cheng D.S., Xia Z.F., Ben D.F., Lu W., Cao Z.F., et al. Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair Regen. 15 (2007) 795-799